Susumu Yamaki

This inventor holds 16 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 9 EPO patents. Top assignees: Astellas Pharma Gmbh, Cytokinetics, Inc., Takeda Pharmaceutical Company Limited. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susumu Yamaki. Retrieved from https://idiyas.com/inventor/susumu-yamaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 3)

% Patents Active = 75.0

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 9 (Patent Applications = 12)

Average Co-Inventor Count = 10.1

ph-index = 3

Forward Citations = 58(Granted Patents)

Location History:

Chuo-ku, JP (2014 - 2017)
Tokyo, JP (2012 - 2024)

Company Filing History:

Takeda Pharmaceutical Company Limited

patents

4. 1 out of 1

Tenvie Therapeutics, Inc.

patent

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12741942 - Substituted pyridazine compound (2026-09-22),

2. 12441691 - Bicyclic 1,4-diazepanones and therapeutic uses thereof (2025-10-14),

3. 11981644 - Bicyclic 1,4-diazepanones and therapeutic uses thereof (2024-05-14),

4. 11479561 - Tetrahydroisoquinoline derivatives (2022-10-25),

5. 10774082 - Quinazoline compound (2020-09-15),

6. 10689393 - Tetrahydroisoquinoline derivatives (2020-06-23),

7. 10556906 - Quinazoline compound (2020-02-11),

8. 10259821 - Tetrahydroisoquinoline derivatives (2019-04-16),

9. 9969709 - Guanidinobenzoic acid ester compound (2018-05-15),

10. 9914741 - Tetrahydroisoquinoline derivatives (2018-03-13),

11. 9556160 - Guanidine compound (2017-01-31),

12. 9199927 - Guanidinobenzoic acid compound (2015-12-01),

13. 9051283 - Guanidine compound (2015-06-09),

14. 8802679 - Glycine compound (2014-08-12),

15. 8716470 - Guanidine compound (2014-05-06),

Title: The Innovative Contributions of Susumu Yamaki

Introduction

Susumu Yamaki is a prominent inventor based in Tokyo, Japan, known for his significant contributions to the field of pharmaceuticals. With a total of 14 patents to his name, he has made remarkable advancements in the treatment of various diseases and disorders.

Latest Patents

Yamaki's latest patents include groundbreaking compounds such as bicyclic 1,4-diazepanones, which have therapeutic uses. These compounds are designed to treat diseases responsive to the modulation of the contractility of the skeletal sarcomere. Additionally, he has developed novel tetrahydroisoquinoline derivative compounds that serve as active ingredients in pharmaceutical compositions aimed at preventing or treating neuromuscular disorders and other related conditions.

Career Highlights

Throughout his career, Susumu Yamaki has worked with notable companies, including Astellas Pharma GmbH and Cytokinetics, Inc. His work has focused on innovative solutions that address critical health issues, particularly those affecting muscle function and contractility.

Collaborations

Yamaki has collaborated with esteemed colleagues such as Bradley Paul Morgan and Scott E Collibee. These partnerships have fostered a collaborative environment that enhances the development of effective pharmaceutical solutions.

Conclusion

Susumu Yamaki's contributions to the field of pharmaceuticals through his patents and collaborations highlight his dedication to innovation and improving health outcomes

Profile summary based on public USPTO records.